# Datavault AI Inc.: financial statements, quarterly

DVLT · Nasdaq · CIK 1682149 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dvlt.md) · [Financials](/companies/dvlt/financials.md) · [Filings](/companies/dvlt/filings.md) · [Insiders](/companies/dvlt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dvlt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.8](/filings/0001410578-24-001990.md) | [0.4 d](/filings/0001410578-25-000600.md) | [0.3](/filings/0001410578-25-001273.md) | [0.3](/filings/0001410578-25-001857.md) | [1.2](/filings/0001104659-25-112637.md) | [0.9 d](/filings/0001104659-26-031280.md) | [0.6](/filings/0001682149-26-000008.md) | [1.7](/filings/0001628280-26-058013.md) | [2.9](/filings/0001104659-25-112637.md) | [33.8 d](/filings/0001104659-26-031280.md) | [3.4](/filings/0001682149-26-000008.md) | [6.7](/filings/0001628280-26-058013.md) |
| Cost of revenue | $m | [2.4](/filings/0001410578-24-001990.md) | [0.8 d](/filings/0001410578-25-000600.md) | [0.3](/filings/0001410578-25-001273.md) | [0.3](/filings/0001410578-25-001857.md) | [0.9](/filings/0001104659-25-112637.md) | [0.7 d](/filings/0001104659-26-031280.md) | [0.6](/filings/0001682149-26-000008.md) | [1.7](/filings/0001628280-26-058013.md) | [2.8](/filings/0001104659-25-112637.md) | [3.6 d](/filings/0001104659-26-031280.md) | [3.3](/filings/0001682149-26-000008.md) | [3.8](/filings/0001628280-26-058013.md) |
| Gross profit | $m | [(1.7)](/filings/0001410578-24-001990.md) | [(0.3) d](/filings/0001410578-25-000600.md) | [(0.1)](/filings/0001410578-25-001273.md) | [0.0](/filings/0001410578-25-001857.md) | [0.2](/filings/0001104659-25-112637.md) | [0.2 d](/filings/0001104659-26-031280.md) | [0.1](/filings/0001682149-26-000008.md) | [0.0](/filings/0001628280-26-058013.md) | [0.1](/filings/0001104659-25-112637.md) | [30.2 d](/filings/0001104659-26-031280.md) | [0.1](/filings/0001682149-26-000008.md) | [2.9](/filings/0001628280-26-058013.md) |
| Research and development | $m | [1.8](/filings/0001410578-24-001990.md) | [1.8 d](/filings/0001410578-25-000600.md) | [1.7](/filings/0001410578-25-001273.md) | [1.8](/filings/0001410578-25-001857.md) | [2.2](/filings/0001104659-25-112637.md) | [2.1 d](/filings/0001104659-26-031280.md) | [2.4](/filings/0001682149-26-000008.md) | [4.2](/filings/0001628280-26-058013.md) | [5.0](/filings/0001104659-25-112637.md) | [4.9 d](/filings/0001104659-26-031280.md) | [5.7](/filings/0001682149-26-000008.md) | [7.2](/filings/0001628280-26-058013.md) |
| Operating income | $m | [(6.3)](/filings/0001410578-24-001990.md) | [(4.6) d](/filings/0001410578-25-000600.md) | [(4.2)](/filings/0001410578-25-001273.md) | [(5.4)](/filings/0001410578-25-001857.md) | [(5.2)](/filings/0001104659-25-112637.md) | [(6.3) d](/filings/0001104659-26-031280.md) | [(9.4)](/filings/0001682149-26-000008.md) | [(12.5)](/filings/0001628280-26-058013.md) | [(14.8)](/filings/0001104659-25-112637.md) | [4.2 d](/filings/0001104659-26-031280.md) | [(31.0)](/filings/0001682149-26-000008.md) | [(26.5)](/filings/0001628280-26-058013.md) |
| Interest expense | $m | [0.1](/filings/0001410578-23-002485.md) | [0.1 d](/filings/0001410578-25-000600.md) | [1.3](/filings/0001410578-25-001273.md) | [0.0](/filings/0001410578-25-001857.md) | [(0.0)](/filings/0001104659-25-112637.md) | [0.0 d](/filings/0001104659-26-031280.md) | [0.1](/filings/0001682149-26-000008.md) | [17.2](/filings/0001628280-26-058013.md) | [0.9](/filings/0001104659-25-112637.md) | [1.8 d](/filings/0001104659-26-031280.md) | [1.1](/filings/0001682149-26-000008.md) | [1.0](/filings/0001628280-26-058013.md) |
| Income tax | $m | [0.0](/filings/0001410578-24-001990.md) | [0.0 d](/filings/0001410578-25-000600.md) | [0.0](/filings/0001410578-25-001273.md) | [0.0](/filings/0001410578-24-001446.md) | [0.0](/filings/0001410578-24-001990.md) | [0.0 d](/filings/0001410578-25-000600.md) | [0.0](/filings/0001682149-26-000008.md) | [0.0](/filings/0001628280-26-058013.md) | [0.0 d](/filings/0001104659-25-112637.md) | [0.0 d](/filings/0001104659-26-031280.md) | [0.0](/filings/0001682149-26-000008.md) | [0.0](/filings/0001628280-26-058013.md) |
| Net income | $m | [(6.1)](/filings/0001410578-24-001990.md) | [(6.4) d](/filings/0001410578-25-000600.md) | [2.7](/filings/0001104659-25-112637.md) | [(42.7)](/filings/0001104659-25-112637.md) | [(5.1)](/filings/0001104659-25-112637.md) | [(6.4) d](/filings/0001104659-26-031280.md) | [(9.6)](/filings/0001628280-26-058013.md) | [(37.1)](/filings/0001628280-26-058013.md) | [(33.0)](/filings/0001104659-25-112637.md) | [0.7 d](/filings/0001104659-26-031280.md) | [(53.1)](/filings/0001628280-26-058013.md) | [(88.0)](/filings/0001628280-26-058013.md) |
| Diluted EPS | $ per share | [(144.98)](/filings/0001410578-24-001990.md) | not reported | [(5.35)](/filings/0001410578-25-001273.md) | [(11.89)](/filings/0001410578-25-001857.md) | [(1.39)](/filings/0001104659-25-112637.md) | not reported | [(0.18)](/filings/0001682149-26-000008.md) | [(0.54)](/filings/0001628280-26-058013.md) | [(0.33)](/filings/0001104659-25-112637.md) | not reported | [(0.09)](/filings/0001682149-26-000008.md) | [(0.12)](/filings/0001628280-26-058013.md) |
| Basic EPS | $ per share | [(144.98)](/filings/0001410578-24-001990.md) | not reported | [(5.35)](/filings/0001410578-25-001273.md) | [(11.89)](/filings/0001410578-25-001857.md) | [(1.39)](/filings/0001104659-25-112637.md) | not reported | [(0.18)](/filings/0001682149-26-000008.md) | [(0.54)](/filings/0001628280-26-058013.md) | [(0.33)](/filings/0001104659-25-112637.md) | not reported | [(0.09)](/filings/0001682149-26-000008.md) | [(0.12)](/filings/0001628280-26-058013.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.2](/filings/0001410578-23-002485.md) | [0.4](/filings/0001410578-25-000600.md) | [2.8](/filings/0001410578-24-000930.md) | [6.1](/filings/0001410578-24-001446.md) | [3.9](/filings/0001410578-24-001990.md) | [3.3](/filings/0001104659-26-031280.md) | [0.2](/filings/0001410578-25-001273.md) | [0.7](/filings/0001410578-25-001857.md) | [1.7](/filings/0001104659-25-112637.md) | [2.0](/filings/0001628280-26-058013.md) | [2.2](/filings/0001682149-26-000008.md) | [1.4](/filings/0001628280-26-058013.md) |
| Current assets | $m | [4.8](/filings/0001410578-23-002485.md) | [4.1](/filings/0001410578-25-000600.md) | [6.2](/filings/0001410578-24-000930.md) | [10.0](/filings/0001410578-24-001446.md) | [7.1](/filings/0001410578-24-001990.md) | [6.4](/filings/0001104659-26-031280.md) | [2.7](/filings/0001410578-25-001273.md) | [3.8](/filings/0001410578-25-001857.md) | [16.5](/filings/0001104659-25-112637.md) | [143](/filings/0001628280-26-058013.md) | [106](/filings/0001682149-26-000008.md) | [135](/filings/0001628280-26-058013.md) |
| Total assets | $m | [5.5](/filings/0001410578-23-002485.md) | [4.8](/filings/0001410578-25-000600.md) | [6.9](/filings/0001410578-24-000930.md) | [10.6](/filings/0001410578-24-001446.md) | [8.0](/filings/0001410578-24-001990.md) | [101](/filings/0001104659-26-031280.md) | [95.7](/filings/0001410578-25-001273.md) | [121](/filings/0001410578-25-001857.md) | [139](/filings/0001104659-25-112637.md) | [275](/filings/0001628280-26-058013.md) | [250](/filings/0001682149-26-000008.md) | [277](/filings/0001628280-26-058013.md) |
| Current liabilities | $m | [3.8](/filings/0001410578-23-002485.md) | [3.6](/filings/0001410578-25-000600.md) | [4.3](/filings/0001410578-24-000930.md) | [3.6](/filings/0001410578-24-001446.md) | [3.1](/filings/0001410578-24-001990.md) | [4.1](/filings/0001104659-26-031280.md) | [4.2](/filings/0001410578-25-001273.md) | [8.1](/filings/0001410578-25-001857.md) | [24.2](/filings/0001104659-25-112637.md) | [26.9](/filings/0001628280-26-058013.md) | [23.0](/filings/0001682149-26-000008.md) | [27.3](/filings/0001628280-26-058013.md) |
| Total liabilities | $m | [4.6](/filings/0001410578-23-002485.md) | [9.7](/filings/0001410578-25-000600.md) | [9.6](/filings/0001410578-24-000930.md) | [4.2](/filings/0001410578-24-001446.md) | [3.7](/filings/0001410578-24-001990.md) | [14.9](/filings/0001104659-26-031280.md) | [14.0](/filings/0001410578-25-001273.md) | [46.6](/filings/0001410578-25-001857.md) | [39.2](/filings/0001104659-25-112637.md) | [36.7](/filings/0001628280-26-058013.md) | [30.1](/filings/0001682149-26-000008.md) | [30.7](/filings/0001628280-26-058013.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [0.6](/filings/0001410578-23-002485.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [0.9](/filings/0001410578-24-001990.md) | [(5.2)](/filings/0001104659-26-031280.md) | [(2.7)](/filings/0001104659-25-112637.md) | [6.4](/filings/0001104659-25-112637.md) | [4.3](/filings/0001104659-25-112637.md) | [85.7](/filings/0001628280-26-058013.md) | [81.7](/filings/0001628280-26-058013.md) | [74.1](/filings/0001628280-26-058013.md) | [99.5](/filings/0001104659-25-112637.md) | [238](/filings/0001628280-26-058013.md) | [220](/filings/0001628280-26-058013.md) | [246](/filings/0001628280-26-058013.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.0) d](/filings/0001410578-24-001990.md) | [(2.7) d](/filings/0001410578-25-000600.md) | [(3.5)](/filings/0001410578-25-001273.md) | [(5.5) d](/filings/0001410578-25-001857.md) | [(4.2) d](/filings/0001104659-25-112637.md) | [(4.3) d](/filings/0001104659-26-031280.md) | [(6.0)](/filings/0001682149-26-000008.md) | [(6.8) d](/filings/0001628280-26-058013.md) | [(10.4) d](/filings/0001104659-25-112637.md) | [(0.4) d](/filings/0001104659-26-031280.md) | [(8.7)](/filings/0001682149-26-000008.md) | [(71.2) d](/filings/0001628280-26-058013.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001410578-24-001990.md) | [0.0 d](/filings/0001410578-25-000600.md) | [0.0](/filings/0001410578-25-001273.md) | [0.0 d](/filings/0001410578-25-001857.md) | [0.0 d](/filings/0001104659-25-112637.md) | [0.0 d](/filings/0001104659-26-031280.md) | [0.1](/filings/0001682149-26-000008.md) | [0.0 d](/filings/0001628280-26-058013.md) | [0.0 d](/filings/0001104659-25-112637.md) | [0.3 d](/filings/0001104659-26-031280.md) | [0.3](/filings/0001682149-26-000008.md) | [0.3 d](/filings/0001628280-26-058013.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.2](/filings/0001410578-23-002485.md) | [0.0](/filings/0001410578-24-000930.md) | [0.0](/filings/0001410578-24-001446.md) | [0.0](/filings/0001410578-24-001990.md) | [0.6](/filings/0001410578-25-001273.md) | [3.6](/filings/0001410578-25-001857.md) | [5.3](/filings/0001104659-25-112637.md) | [53.7](/filings/0001682149-26-000008.md) | [68.2](/filings/0001628280-26-058013.md) | [101](/filings/0001104659-25-112637.md) | [574](/filings/0001682149-26-000008.md) | [728](/filings/0001628280-26-058013.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 949,728,605 at 2026-08-19, from the cover of the [10-Q filed 2026-08-19](/filings/0001628280-26-058013.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.